Patents
Patents for C07D 211 - Heterocyclic compounds containing hydrogenated pyridine rings, not condensed with other rings (37,939)
06/2005
06/15/2005CN1628100A Gamma secretase inhibitors
06/15/2005CN1628099A Water soluble phenylglycine derivatives
06/15/2005CN1206219C N-ureidoalkyl-piperidines as modulators of chemokine receptor activity
06/14/2005US6906632 Vehicular sound-processing system incorporating an interior mirror user-interaction site for a restricted-range wireless communication system
06/14/2005US6906192 Processes for the preparation of acid derivatives useful as serine protease inhibitors
06/14/2005US6906083 Alzheimer's disease; brain disorders
06/14/2005US6906081 For treatment of Alzheimer's disease, learning disabilities
06/14/2005US6906079 Method and reagents for N-alkylating ureides
06/14/2005US6906072 Central nervous system disorders
06/14/2005US6906066 N-ureidoalkyl-piperidines as modulators of chemokine receptor activity
06/14/2005CA2304967C 4(3)substituted-4(3)-aminomethyl-(thio)pyran or -piperidine derivatives (=gabapentin analogues), their preparation and their use in the treatment of neurological disorders
06/14/2005CA2234096C 1-(1,2-disubstituted piperidinyl)-4-substituted piperazine derivatives
06/14/2005CA2155952C Novel process for trans-6-[2-(substituted-pyrrol-1-yl)alkyl]pyran-2-one inhibitors of cholesterol synthesis
06/09/2005WO2005051913A1 Cyclic amine derivative having heteroaryl ring
06/09/2005WO2005051912A1 Piperidine compound and method for producing same
06/09/2005WO2005051911A1 4-phenylpiperidine derivatives as renin inhibitors
06/09/2005WO2005051390A1 E-fluoro-4-(pyridin-2-yl)-piperidine-1-carboxamide derivatives and related compounds which modulate the function of the vanilloid-1 receptor (vr1) for the treatment of pain
06/09/2005WO2005051386A1 Hmg-coa reductase inhibitors and method
06/09/2005WO2005034184A3 Lighting elements, devices and methods
06/09/2005WO2005028425A3 Amidines and derivatives thereof and pharmaceutical compositions containing them
06/09/2005WO2005016261A3 Aripiprazole and haloperidol pamoate salts
06/09/2005WO2004052845A8 Tetrahydro-naphthalene derivatives as vanilloid receptor antagonists
06/09/2005US20050124671 Benzylcycloalkyl amines as modulators of chemokine receptor activity
06/09/2005US20050124656 Substituted methylene amide derivatives as modulators of protein tyrosine phosphatases(ptps)
06/09/2005US20050124654 Compounds and methods of use
06/09/2005US20050124642 (1-Indanone)-(1,2,3,6-tetrahydropyridine) compounds
06/09/2005US20050124634 1,4-dihydropyridine compounds, pharmaceutical compositions, and methods for the treatment of cardiovascular disease
06/09/2005US20050124633 For the treatment of myosin heavy chain-mediated diseases, and in particular, heart failure
06/09/2005US20050124602 1-(3-chlorophenyl)-7-oxo-6-[4-(2-oxo-1(2H)pyridinyl)phenyl]-4,5,6,7-tetrahydro-1H-pyrazolo[3,4-c]pyridine-3-carboxamide; treating a thromboembolic disorder such as deep vein thrombosis or pulmonary embolism
06/09/2005US20050124069 Transfection reagents
06/09/2005US20050123935 For use in multicolor/multiplexing assays; bioconjugation; kits
06/09/2005DE10353910A1 Verfahren zur Synthese optisch aktiver Piperidine Process for the synthesis of optically active piperidines
06/09/2005DE102004054421A1 Geliermittel für Öl Gelling agent for oil
06/09/2005CA2547472A1 Cyclic amine derivative having heteroaryl ring
06/09/2005CA2547467A1 Piperidine compound and method for producing same
06/09/2005CA2546264A1 4-phenylpiperidine derivatives as renin inhibitors
06/08/2005EP1538150A1 Novel pleuromutilin derivatives
06/08/2005EP1537083A1 S-(-)-amlodipine nicotinate and process for the preparation thereof
06/08/2005EP1537082A1 Processes for the preparation of s-(-)-amlodipine
06/08/2005EP1537081A1 Dihydropyridine derivatives for use as human neutrophil elastase inhibitors
06/08/2005EP1537074A1 Cathepsin cysteine protease inhibitors
06/08/2005EP1536797A1 1-amido-4-phenyl-4-benzyloxymethyl-piperidine derivatives and related comounds as neurokinin-1 (nk-1) antagonsists for the treatment of emesis, depression, anxiety and cough
06/08/2005EP1536796A1 N-aryl piperidine substituted biphenylcarboxamides as inhibitors of apolipoprotein b secretion
06/08/2005EP1536795A1 Inverse agonists acting at virus-encoded g protein-coupled receptors
06/08/2005EP1370528B1 Mch antagonists and their use in the treatment of obesity
06/08/2005EP1220831B1 Biaryl ether derivatives useful as monoamine reuptake inhibitors
06/08/2005EP0922029B1 Ether muscarinic antagonists
06/08/2005EP0849256B1 Amide compounds and use of the same
06/08/2005CN1625554A Amides of aminoalkyl substituted azetidines, pyrrolidines, piperidines and azepanes
06/08/2005CN1623985A Processes for preparing anhydrous and hydrate forms of antihistaminic piperidine derivatives, polymorphs and pseudomorphs thereof
06/08/2005CN1205211C Pleuromutilin derivatives as antimicrobials
06/08/2005CN1205185C Nitrogenous cyclic compounds and pharmaceutical compositions containing the same
06/08/2005CN1205180C 3-(2,5-diaminophenyl)-acrylamide derivatives and colouring agents containing said compounds
06/08/2005CN1205179C (P-amino-hydroxyphenyl)-acrylamide derivatives and dyes containing said compounds
06/08/2005CN1204881C Use of allylamine derivatives in the manufacture of a medicament for the treatment of helicobacter pylori infection and correlation diseases
06/07/2005US6903232 Via crystallization of mixture of para-/meta- regioisomers; for production of terfenadine carboxylate
06/07/2005US6903124 Organic acid salt of amlodipine
06/07/2005US6903120 Modulators of dopamine neurotransmission
06/07/2005US6903115 Bipiperidine compounds
06/07/2005US6903103 Linear cyclic ureas
06/07/2005US6903102 17β-hydroxysteroid dehydrogenase type 3 inhibitors for the treatment of androgen dependent diseases
06/07/2005US6903088 Compounds which inhibit leukocyte adhesion mediated by VLA-4
06/07/2005US6903085 Substituted piperidine compounds useful as modulators of chemokine receptor activity
06/07/2005CA2299036C 4-phenyl-4-heteroarylpiperidine derivatives
06/02/2005WO2005049594A1 N-acylsulfonamide apoptosis promoters
06/02/2005WO2005049593A2 N-acylsulfonamide apoptosis promoters
06/02/2005WO2005049571A1 Process for preparation of chiral amlodipine salts
06/02/2005WO2005049570A1 Method for synthesising optically active piperidines by the hydrogenation of optically active pyridines
06/02/2005WO2005049565A1 N-sulfonyldicarboximide containing tethering compounds
06/02/2005WO2005023794A3 Compound libraries of 4-carboxamidopiperidine derivatives
06/02/2005WO2004063150A3 Diagnostic and therapeutic alkyl piperidine/piperazine compounds and process
06/02/2005US20050119416 Ring-opening or closing metathesis reaction of olefin; reduction of carbonyl compound, catalysis, complexing; cyclization, reduction
06/02/2005US20050119310 nucleoside / nucleitide antiviral agents [2'-deoxy-3'-thiocytidine-5'-triphosphate (3TC)]; immunomodulators / immunostimulants; synergistic effect; prevent drug resistance; reduce toxicity
06/02/2005US20050119309 Compositions and methods for selective inhibition of nicotine acetylcholine receptors
06/02/2005US20050119307 Method of treating attention deficit disorders with D-threo methylphenidate
06/02/2005US20050119264 Tetrahydrobenzfluorene derivatives
06/02/2005US20050119250 Amino-derivatives as novel inhibitors of histone deacetylase
06/02/2005US20050119227 Cyclic amine bace-1 inhibitors having a benzamide substituent
06/01/2005EP1535909A2 Cyclic amine derivatives and their use as drugs
06/01/2005EP1534695A2 Tyrosine kinase inhibitors
06/01/2005EP1534693A2 1, 3-diamino-2-hydroxypropane prodrug derivatives
06/01/2005EP1534689A1 Novel carboxamide compounds having an mch-antagonistic effect, medicaments containing said compounds, and methods for the production thereof
06/01/2005EP1534678A1 Pleuromutilin derivatives as antimicrobbials
06/01/2005EP1534677A1 Piperidine derivatives and their use as selective inhibitors of mip-1alpha binding to its receptor ccr1
06/01/2005EP1534676A1 Piperidinetriol derivatives as inhibitors of glycosylceramide synthase
06/01/2005EP1534663A1 N-bridged selective androgen receptor modulators and methods of use thereof
06/01/2005EP1534658A2 Ketone ligands for modulating the expression of exogenous genes via an ecdysone receptor complex
06/01/2005EP1534281A1 N-sulfonylpiperidines as metalloproteinase inhibitors (tace)
06/01/2005EP1534280A1 Aryl piperidine derivatives and use thereof to reduce elevated levels of ldl-cholesterol
06/01/2005EP1440118B1 Blends of waxes and polymer additives
06/01/2005EP1436280B1 A process for preparing 4-(hydroxy)- 1,4']bipiperidinyl-l'carboxylic acid tert-butyl ester
06/01/2005EP1351959B1 Novel pleuromutilin derivatives
06/01/2005EP1347760B1 Nmda receptor agonist pharmaceutical compositions
06/01/2005EP1049679B1 Sulphonamide derivatives for treatment of cns disorders
06/01/2005CN1204121C 1, 4-substituted cyclic amine derivatives or dihydro indole derivatives and medicines containing same
05/2005
05/31/2005US6900345 Antibiotics; mutilin 14-[N-(2-carbamoyloxyethoxycarbonyl)]carbamate; therapy for bacteria infections; chemical synthesis
05/31/2005US6900329 MCH antagonists and their use in the treatment of obesity
05/31/2005US6900328 Stabilizer for polymers; photostability, oxidation resistance
05/31/2005US6900327 Used as antidepressants, to treat obsessive compulsive disorder, panic disorders, bulimia, anorexia, pain, obesity, senile demential, migraines, and social phobias
05/31/2005US6900326 Reacting mesyl chloride with n-aralkylpiperidien compound in presence of a base; then a dicarbonate; chemical intermediate for drug